Submit Deal

SURROZEN INC

Summary

Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 154 M

Avg. Deal Size£ 154 M

Market Context

Senior Management

Sort

Target: SURROZEN INC

Bidder: CONSONANCE-HFW ACQUISITION

13 Service Providers

35 Dealmakers

£ 153 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy